Treatment of a low immunogenic experimental tumour with alloactivated or tumour-immune lymphocytes (original) (raw)
Adoptive immunotherapy of cancer with immune and activated lymphocytes: experimental and clinical studies
Monica Rodolfo
La Ricerca in clinica e in laboratorio
View PDFchevron_right
Cross-reactions between tumor cells and allogeneic normal tissues. inhibition of a syngeneic lymphoma outgrowth in h-2 and non-h-2 alloimmune balb/c mice
dario ballinari
International Journal of Cancer, 1982
View PDFchevron_right
Immunogenicity and immunosensitivity of ex vivo human carcinomas: interferon ? and tumour necrosis factor ? treatment of tumour cells potentiates their interaction with autologous blood lymphocytes
Luis Carlos Rodriguez Alvarez
Cancer Immunology Immunotherapy, 1995
View PDFchevron_right
Immunization with Chemically Modified Lymphoma Cells1
Joseph P Cotropia
View PDFchevron_right
Protection against transplanted and spontaneous lymphoma by inoculation of heat-altered syngeneic tumor cells in splenectomized mice
Luther Brady
Cancer, 1974
View PDFchevron_right
Adoptive immunotherapy of a BALB/c lymphoma by syngeneic anti-DBA/2 immune lymphoid cells: Characterization of the effector population and evidence for the role of the host's non-T cells
Mario Colombo
Cancer Immunology Immunotherapy, 1985
View PDFchevron_right
Human tumor-lymphocyte interactionin vitro. III. T lymphocytes in autologous tumor stimulation (ATS)
Árpád Péterffy
International Journal of Cancer, 1978
View PDFchevron_right
Inhibition of murine lymphoma growth by adoptive transfer of lymphocytes sensitized to a xenogenized tumor variant
Roberta Bianchi
International Journal of Cancer, 1987
View PDFchevron_right
Passive adoptive immunotherapy of low-immunogenic BALB/C lymphoma by syngeneic alloimmune T lymphocytes
Mario Colombo
International Journal of Cancer, 1984
View PDFchevron_right
In vitro induction of tumor specific immunity: requirements for T lymphocytes and tumor growth inhibitionin vivo
Hermann Wagner
European Journal of Immunology, 1973
View PDFchevron_right
Tumour immunotherapy
Miroslav Malkovsky
Current Opinion in Immunology, 1989
View PDFchevron_right
Effect of tumor cells on the generation of cytotoxic T lymphocytes in vitro
Hillel Koren
European Journal of Immunology, 1977
View PDFchevron_right
Immune responses to weakly immunogenic virally induced tumors I. Overcoming low responsiveness by priming mice with a syngeneicin vitro tumor line or allogeneic cross-reactive tumor
David Naor
European Journal of Immunology, 1978
View PDFchevron_right
Cancer Immunology and Immunotherapy
Swaleha Zubair
Current Topics in Microbiology and Immunology, 2011
View PDFchevron_right
A lymphocyte-activating monoclonal antibody induces regression of human tumors in severe combined immunodeficient mice
Britta Hardy, Annat Raiter
Proceedings of the National Academy of Sciences, 1997
View PDFchevron_right
Untreated or drug-treated tumor cells are differentially recognized by allogeneic lymphocytes
Stephen E Christmas
International Journal of Immunopharmacology, 1994
View PDFchevron_right
Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials
Diane Solomon
Journal of Immunological Methods, 1987
View PDFchevron_right
Immune reactivity in SL2 lymphoma-bearing mice compared with SL2-immunized mice
Roel Rios Rios
Cancer Immunology Immunotherapy, 1987
View PDFchevron_right
Differentiation of antitumor-specific cytotoxic T lymphocytes from autologous tumor infiltrating lymphocytes in non-Hodgkin’s lymphomas
Marie-hélène Delfau-larue
Experimental Hematology, 1999
View PDFchevron_right
The determinants of tumour immunogenity
Eneron TurboPot
View PDFchevron_right
Lymphoid cell subpopulations infiltrating into autologous rat tumors undergoing rejection
Akihiro Matsuura
Cancer research, 1984
View PDFchevron_right
Separable Populations of Activated Thymus-Derived Lymphocytes Identified in Two Assays for Cell-Mediated Immunity to Murine Tumor Allografts
Reg Gorczynski
Journal of Experimental Medicine, 1974
View PDFchevron_right
Cytotoxic T Cell Responses to a Syngeneic Tumour: Conditions for Primary Activation in Vitro
Charles Denaro
Australian Journal of Experimental Biology and Medical Science, 1978
View PDFchevron_right
Characterization of factors regulating successful immunotherapy using a tumor-specific cytotoxic T lymphocyte clone: Role of interleukin-2, cycling pattern of lytic activity and adhesion molecules
Prakash Nagarkatti
International Journal of Cancer, 1995
View PDFchevron_right
Specific cytotoxic lymphocytes against syngeneic tumors are generated in culture in the presence of syngeneic, but not xenogeneic, serum
Mina Fogel
International Journal of Cancer, 1978
View PDFchevron_right
Lymphoid populations in tumour reactive lymph nodes
Francisco Gambón
Immunology Letters, 1997
View PDFchevron_right
Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity ofin vitro generated secondary CTL with syngeneic tumor cells
C. victor Jongeneel
European Journal of Immunology, 1976
View PDFchevron_right
L-5178-Y lymphoma associated immunosuppression in Balb/c mice
Alejandro Bravo Cuellar
Biomedicine & Pharmacotherapy, 1995
View PDFchevron_right
Tumours: Immunotherapy
Eman M Younis
View PDFchevron_right
Stimulation of thymus- and bone marrow-derived lymphocytes by tumor cells in culture
Martyn Burk
Cancer research, 1977
View PDFchevron_right
Folia Biologica (Praha) 51, 159-165 (2005) Original Articles Immune Characterization of the Lewis Rats Inoculated with K2 Sarcoma Cell Line and Newly Derived R5-28 Malignant Cells ( rat sarcoma / malignancy / myeloid cells / splenomegaly / natural killer
Alena Morávková
2020
View PDFchevron_right
Activated T lymphocytes within human solid tumors
Luis Carlos Udaeta Rodriguez
Cancer Immunology Immunotherapy, 1979
View PDFchevron_right
Susceptibility of chemoresistant murine and human tumor cells to lysis by Interleukin 2-Activated lymphocytes
Monica Rodolfo
Cancer Research
View PDFchevron_right